Crism Therapeutics annual net profit margin
2023
2024
2025
Crism Therapeutics Net Profit Margin Growth & History (CRTX)
Crism Therapeutics's net profit margin was −823.81% for fiscal 2025.
View full Crism Therapeutics company overviewCrism Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −823.81% | +1604.19 pp |
| 2024 | 2024-12-31 | −2,428.00% | −1992.44 pp |
| 2023 | 2023-12-31 | −435.56% | — |
Crism Therapeutics net profit margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Crism Therapeutics's net profit margin decreased from −435.56% to −823.81%, a change of −388.25 percentage points.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as reported net income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crism Therapeutics source filings ↗Community posts
CRISM reports higher development spending and a £1.41 million loss
CRISM Therapeutics ($CRTX) reported a first-half loss of £1.413 million, compared with £0.930 million a year earlier. Administrative expenses reached £1.52 million, including £956,000 of research and development spending. Operating cash out ...
